Torben Mogensen
Director/Board Member at Augusta Victoria Hospital
Network origin in Torben Mogensen first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 7 | |
Lanzhou University
3
| College/University | Other Consumer Services | 3 |
Augusta Victoria Hospital
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Torben Mogensen via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| MOBERG PHARMA AB | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
| BIOSERGEN AB | Biotechnology | Chairman Director/Board Member | |
Palette Life Sciences AB
 Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member Director/Board Member | |
Palette Life Sciences, Inc.
 Palette Life Sciences, Inc. Medical SpecialtiesHealth Technology Part of Palette Life Sciences AB, Palette Life Sciences, Inc. operates as a medical device company. The company is based in Santa Barbara, CA. The CEO of the company is Per Langoe. | Medical Specialties | Director/Board Member Director/Board Member | |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| AEROCRINE AB | Electronic Equipment/Instruments | President | |
| COMBIGENE AB | Pharmaceuticals: Major | Director/Board Member | |
J&J Future Invest AS
 J&J Future Invest AS Real Estate DevelopmentFinance J & J Future Invest AS is a Norwegian company that operates a real estate agency. | Real Estate Development | Corporate Officer/Principal | |
| PCI BIOTECH HOLDING ASA | Biotechnology | Director/Board Member | |
Blueprint Genetics Oy
 Blueprint Genetics Oy BiotechnologyHealth Technology Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland. | Biotechnology | Chairman | |
Bio-Me AS
 Bio-Me AS BiotechnologyHealth Technology Bio-Me AS operates as a boi-tech firm. It researches and develops patented technologies and new approaches in bacteria analysis. The company is headquartered in Oslo, Norway. | Biotechnology | Director/Board Member | |
| Tappin AS | Director/Board Member | ||
| BERGENBIO ASA | Pharmaceuticals: Major | Chairman | |
| HERANTIS PHARMA OYJ | Pharmaceuticals: Major | Director/Board Member | |
| SEDANA MEDICAL AB | Medical Specialties | Director/Board Member | |
Pluvia AS
 Pluvia AS Miscellaneous Commercial ServicesCommercial Services Pluvia AS operates as a research-based pharmaceutical company. The company is headquartered in Bergen, Norway. | Miscellaneous Commercial Services | Director/Board Member | |
| FANGDA CARBON NEW MATERIAL CO.,LTD | Construction Materials | Director/Board Member | |
| LANZHOU FOCI PHARMACEUTICAL CO.,LTD. | Pharmaceuticals: Other | Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
| Baxter Medical AB | Corporate Officer/Principal | ||
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
Gansu Hongliang Leather Co., Ltd.
 Gansu Hongliang Leather Co., Ltd. Other Consumer SpecialtiesConsumer Durables Gansu Hongliang Leather Co., Ltd. engages in the development, production and sale of leather products. It manufactures leather shoe uppers for mens and womens shoes as well as luggage leather. The company was founded on January 31, 1997 and is headquartered in Linxia, China. | Other Consumer Specialties | Director/Board Member | |
| WEIFA ASA | Pharmaceuticals: Major | Director/Board Member | |
Genzyme Europe BV
 Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The company is based in Amsterdam, Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Oslo | College/University | Graduate Degree | |
Copenhagen Capacity
 Copenhagen Capacity Financial ConglomeratesFinance Copenhagen Capacity provides investment promotion and economic development services. The private company is based in Copenhagen, Denmark. Asbjørn Overgaard Christiansen has been the CEO of the Danish company since 2020. | Financial Conglomerates | Director/Board Member | |
| PROBI AB | Biotechnology | Director/Board Member | |
| DIAMYD MEDICAL AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| KANCERA AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Astra Arcus AB | Corporate Officer/Principal | ||
| SHENGDA RESOURCES CO.,LTD. | Other Metals/Minerals | Director/Board Member | |
Crisis Management Initiative
 Crisis Management Initiative Miscellaneous Commercial ServicesCommercial Services Crisis Management Initiative is an independent Finnish organization that specializes in mediation and dialogue as effective methods for preventing and resolving violent conflicts. The private company is based in Helsinki, Finland. The Finnish company's expertise lies in informal dialogue and mediation, and they aim to consolidate their position as a leading organization in the field of conflict resolution. The company's program for the 2018-2021 period focuses on making meaningful contributions to peace processes in three regions. | Miscellaneous Commercial Services | Director/Board Member | |
| FINNAIR OYJ | Airlines | Director/Board Member | |
Kelonia Oy Ab
 Kelonia Oy Ab Miscellaneous Commercial ServicesCommercial Services Kelonia Oy Ab provides investment services. It specializes in private equity investments. The company was founded on October 11, 1984 and is headquartered in Helsinki, Finland. | Miscellaneous Commercial Services | Director/Board Member | |
| China Securities Law Research Association | Corporate Officer/Principal | ||
Chengdu Sino-Microelectronics Technology Co., Ltd.
 Chengdu Sino-Microelectronics Technology Co., Ltd. SemiconductorsElectronic Technology Chengdu Sino-Microelectronics Technology Co., Ltd. engages in the research, development, design, testing, and sale of integrated circuits for signal processing and control systems. It offers digital integrated circuit products such as logic chips, memory chips and microcontrollers; as well as analog integrated circuit products such as Analog to Digital Converter (ADC), Digital to Analog Converter (DAC), bus interface, power management, and amplifiers. The company was founded on March 9, 2000 and is headquartered in Chengdu, China. | Semiconductors | Director/Board Member | |
| Southwest University of Political & Law | College/University | Undergraduate Degree | |
| Hebei Normal University | College/University | Graduate Degree | |
| Hebei University | College/University | Graduate Degree | |
| SHENWAN HONGYUAN GROUP CO., LTD. | Investment Banks/Brokers | Director/Board Member | |
| SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. | Medical Distributors | Director/Board Member | |
| NANNING DEPARTMENT STORE CO., LTD. | Department Stores | Director/Board Member | |
Merz Pharmaceuticals GmbH
 Merz Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Merz Pharmaceuticals GmbH discovers and develops drugs for the treatment of neurological and psychiatric diseases. Its dermatology products focus on the treatment of scars, acne, hair loss and fungal diseases. In the area of metabolic disturbances, it offers therapies for liver disease and lipid metabolism disorders. The company also offers various OTC products, including cold remedies, skin care products and vitamin supplements under the brand names tetesept and Merz Special. The company is headquartered in Frankfurt am Main, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Adelaide | College/University | Doctorate Degree | |
Q-Med AB
 Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| Sweden | 15 |
| China | 13 |
| Norway | 11 |
| United States | 6 |
| Finland | 6 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 6 |
| Finance | 4 |
| Commercial Services | 4 |
| Electronic Technology | 3 |
Operational
| Director/Board Member | 77 |
| Independent Dir/Board Member | 25 |
| Corporate Officer/Principal | 25 |
| Chairman | 15 |
| Chief Executive Officer | 9 |
Most connected contacts
| Insiders | |
|---|---|
| Mattias Klintemar | 28 |
| Pirkko Sulila Tamsen | 23 |
| Hilde Furberg | 21 |
| Gunvor Edith Maria Kronman | 18 |
| Paul de Potocki | 14 |
| Anna Ljung | 12 |
| Lei Zhao | 10 |
| Markus Jerling | 8 |
| Cindy Wong | 6 |
| Xin Cai Gao | 5 |
| Deng Xun Jia | 2 |
- Stock Market
- Insiders
- Torben Mogensen
- Company connections
